BioGaia AB Statistics

Total Valuation

BioGaia AB has a market cap or net worth of SEK 10.12 billion. The enterprise value is 8.87 billion.

Market Cap	10.12B
Enterprise Value	8.87B

Important Dates

The next estimated earnings date is Friday, July 18, 2025.

Earnings Date	Jul 18, 2025
Ex-Dividend Date	May 8, 2025

Share Statistics

BioGaia AB has 102.20 million shares outstanding. The number of shares has increased by 0.13% in one year.

Current Share Class	98.50M
Shares Outstanding	102.20M
Shares Change (YoY)	+0.13%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.15%
Owned by Institutions (%)	44.48%
Float	73.43M

Valuation Ratios

The trailing PE ratio is 32.37 and the forward PE ratio is 25.46.

PE Ratio	32.37
Forward PE	25.46
PS Ratio	7.13
PB Ratio	5.69
P/TBV Ratio	6.25
P/FCF Ratio	28.81
P/OCF Ratio	28.35
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.15, with an EV/FCF ratio of 25.26.

EV / Earnings	28.65
EV / Sales	6.25
EV / EBITDA	20.15
EV / EBIT	21.41
EV / FCF	25.26

Financial Position

The company has a current ratio of 10.84

Current Ratio	10.84
Quick Ratio	8.31
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	206.82

Financial Efficiency

Return on equity (ROE) is 15.69% and return on invested capital (ROIC) is 13.13%.

Return on Equity (ROE)	15.69%
Return on Assets (ROA)	11.48%
Return on Invested Capital (ROIC)	13.13%
Return on Capital Employed (ROCE)	22.02%
Revenue Per Employee	6.34M
Profits Per Employee	1.38M
Employee Count	225
Asset Turnover	0.63
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.30% in the last 52 weeks. The beta is 0.65, so BioGaia AB's price volatility has been lower than the market average.

Beta (5Y)	0.65
52-Week Price Change	-17.30%
50-Day Moving Average	104.86
200-Day Moving Average	112.10
Relative Strength Index (RSI)	42.92
Average Volume (20 Days)	217,328

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioGaia AB had revenue of SEK 1.42 billion and earned 309.74 million in profits. Earnings per share was 3.06.

Revenue	1.42B
Gross Profit	1.03B
Operating Income	414.47M
Pretax Income	396.13M
Net Income	309.74M
EBITDA	431.58M
EBIT	414.47M
Earnings Per Share (EPS)	3.06

Full Income Statement

Balance Sheet

The company has 1.25 billion in cash and n/a in debt, giving a net cash position of 1.25 billion or 12.22 per share.

Cash & Cash Equivalents	1.25B
Total Debt	n/a
Net Cash	1.25B
Net Cash Per Share	12.22
Equity (Book Value)	1.78B
Book Value Per Share	17.59
Working Capital	1.48B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 357.01 million and capital expenditures -5.66 million, giving a free cash flow of 351.35 million.

Operating Cash Flow	357.01M
Capital Expenditures	-5.66M
Free Cash Flow	351.35M
FCF Per Share	3.44

Full Cash Flow Statement

Margins

Gross margin is 72.81%, with operating and profit margins of 29.20% and 21.83%.

Gross Margin	72.81%
Operating Margin	29.20%
Pretax Margin	27.91%
Profit Margin	21.83%
EBITDA Margin	30.41%
EBIT Margin	29.20%
FCF Margin	24.76%

Dividends & Yields

This stock pays an annual dividend of 6.90, which amounts to a dividend yield of 6.65%.

Dividend Per Share	6.90
Dividend Yield	6.65%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	61.94%
Buyback Yield	-0.13%
Shareholder Yield	6.52%
Earnings Yield	3.06%
FCF Yield	3.47%

Dividend Details

Stock Splits

The last stock split was on May 18, 2022. It was a forward split with a ratio of 5.

Last Split Date	May 18, 2022
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a